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PRELIMINARY STUDY OF THE GENETICS OF RESISTANCE IN THE HOUSE MOUSE 
COLIN V. PRESCOTT, School of Animal and Microbial Sciences, University of Reading, Whiteknights, Reading, 
Berkshire RG6 2AJ, United Kingdom. 
ABSTRACT: A wild house mouse (Mus domesticus) population originally trapped near Reading, Berkshire, United 
Kingdom, and maintained as a colony in the laboratory, was subjected to the discriminating feeding period of the 
warfarin resistance test, as used by Wallace and MacSwiney (1976) and derived from the work of Rowe and Redfern 
(1964). Eighty percent of this heterogeneous population survived the resistance test. A similar proportion of the 
population was found to survive the normally lethal dose of bromadiolone administered by oral gavage. The majority 
of this population of mice were classified as "warfarin-resistant" and "bromadiolone-resistant." The dose of 10mg.kg1 
of bromadiolone administered by oral gavage appeared to give good discrimination between susceptible and resistant 
individuals. The results of breeding tests indicate a single dominant gene that confers both "warfarin-resistance" and 
"bromadiolone-resistance," with complete expression of the resistance genotype in both males and females. Individual 
mice were classified as to genotype by back-crossing to a homozygous-susceptible strain, and resistance-testing the Fl 
generation. Separate strains of homozygous-resistant and homozygous-susceptible house mice are now being established. 
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INTRODUCTION 
House mice (Mus domesticus) (Marshall and Sage 
1981) have a naturally low susceptibility to first 
generation anticoagulants. For example, the acute oral 
LDso is reported for warfarin to be 374 mg.kg·• (Hagan 
and Radomski 1953) and for diphacinone to be 250 to 300 
mg.kg·• (ltoh et al. 1973). 
W arfarin resistance in the house mouse was first 
described by Dodsworth (1961), although at that time it 
was not considered to be widespread. Rowe and Redfern 
(1964) acknowledged that some house mouse populations 
were extremely difficult to kill with warfarin and, 
therefore, investigated its toxicity to mice in the 
laboratory. The test animals were obtained from breeding 
pens which were stocked from 13 different localities 
where no previous warfarin treatment had been carried 
out. In the test, individually caged mice were offered an 
unrestricted amount of 250 ppm warfarin for a fixed 
number of days, weighing food consumption, and 
recording survival or mortality. Thirteen mice were 
tested over a 28-day feeding period resulting in complete 
mortality. However, of 53 mice tested over a 21-day 
feeding period, five animals survived. Rowe and Redfern 
(1965) suggested that these survivors are indicative of the 
probable presence of mice "resistant" to 250 ppm 
warfarin in any sizable mouse population. 
Apart from the work of Rowe and Redfern (1964), 
which was concerned specifically with the toxicity of 
warfarin to house mice, there is no published laboratory 
test to identify anticoagulant-resistance in the house 
mouse. On the basis of the results of Rowe and Redfern 
(1964), Wallace and MacSwiney (1976) used a 21-day 
feeding period on a 250 ppm bait as a warfarin-resistance 
test to discriminate between warfarin-resistant and 
warfarin-susceptible individuals. In this way, they were 
able to demonstrate that warfarin resistance in the house 
mouse was controlled by a major resistance gene, which 
they designated "War;" whose expression was very 
variable and strongly influenced by modifiers (MacSwiney 
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and Wallace 1978). 
This paper deals with a stock of wild house mice 
(Mus domesticus) trapped near Reading, Berkshire, 
United Kingdom (UK). The mice were initially shown to 
be resistant to warfarin by the 21-day warfarin feeding 
test (Rowe and Redfern 1964). Subsequently, it was 
found that the warfarin resistant stock were relatively 
resistant to bromadiolone, and a dose of bromadiolone 
was established that would distinguish between the 
susceptible and resistant phenotypes. This was then used 
to demonstrate single factor inheritance of the resistance. 
METHODS 
Wild anticoagulant-resistant stock were derived from 
mice trapped from a warfarin-resistant infestation near 
Reading (Berkshire, UK), and subsequently maintained in 
population pens. The anticoagulant-susceptible stock 
were albino Swiss mice (CD-1) obtained from Charles 
River UK Ltd. 
Except where stated, all animals were maintained on 
laboratory diet (PCD MOD [CJ FG; Special Diet 
Services; Wiltham, Essex, UK). This diet contains a 
supplement of vitamin K3 at 10 ppm. 
Warfarin was obtained as a proprietary 250 ppm bait 
formulation. Bromadiolone was obtained as a proprietary 
0.13 liquid concentrate and as a 0 .233 liquid 
concentrate. The concentrations of warfarin and 
bromadiolone were verified by HPLC. 
Lethal Feeding-Period Test 
Five male and five female wild mice were weighed, 
individually caged in stainless steel test cages with mesh 
floors, and maintained on ground laboratory diet in food 
bowls which were held in place by metal clips. Food 
consumption was measured daily for each mouse, taking 
spillage into account. The test animals were then 
presented with the 250 ppm warfarin diet for a no-choice 
feeding period of 21 days. Again food consumption was 
measured daily for each mouse, taking spillage into 
account. The animals were then maintained on the ground 
laboratory diet for an observation period of 28 days. 
Throughout the experiment, the test animals were 
inspected for signs of toxicosis. At death, or at the end 
of the observation period, the animals were weighed 
again. 
Intubation 
Groups of animals were either received from Charles 
River UK Ltd., or removed from the population pen, and 
maintained in single sexed groups for an acclimatization 
period. They were then weighed, and dosed by gavage 
with the required concentration of bromadiolone at a rate 
of 1 ml per 100 g body weight; to achieve the highest 
dosage of 34.5 mg.kg·•, the 0.233 concentrate was dosed 
at a rate of 1.5 ml per 100 g body weight. Animals were 
not starved prior to dosing. They were then maintained 
in single sex groups for an observation period of 21 days. 
Throughout the experiment, the test animals were 
inspected for signs of toxicosis. 
RESULTS 
Feeding Test With Warfarin 
The results of the 21-day warfarin feeding test are 
presented in Table 1. Only two out of the ten animals 
died. They had consumed less than 30% of the warfarin 
formulation consumed by the survivors. The eight 
survivors showed no reduction in daily food consumption 
during the test, demonstrating a high level of resistance to 
warfarin. The contrast in the amount of active ingredient 
consumed by the survivors and those that died, suggests 
two distinct levels of susceptibility to the anticoagulant. 
The results indicate that 80% of the house mouse stock 
were warfarin-resistant and 20% were warfarin-
susceptible. 
Table l. Wild house mice-mortality and warfarin dose 
consumed during 21-day no-choice feed on warfarin bait. 
Dose of warfarin consumed (mg.kg.1) 
Survived Died 
Sex Mortality mean (range) mean (range) 
Male 0/5 
Female 2/5 
808 (657-1084) 
973 (842-1077) 
Bromadiolone Toxicity By Gavage 
195 (149-241) 
The results of the initial bromadiolone gavage tests 
with the "Reading" house mice are presented in Table 2. 
Of the 30 mice that received a potentially lethal dose of 
bromadiolone, three animals died (10%). The proportion 
of animals that survived bromadiolone was comparable 
with the 80 % of animals that survived the 21-day warfarin 
feeding test, suggesting a high level of cross-resistance 
between the two anticoagulants. 
The results of the bromadiolone gavage tests with the 
anticoagulant-susceptible Swiss mice are presented in 
Table 3. A bromadiolone dose of 1.8 mg.kg·• body 
weight achieved incomplete mortality in both males and 
females. A dose of 0 .9 mg.kg·• gave no mortality, and a 
dose of 3.6 mg.kg·• and above, gave complete mortality. 
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Table 2. Wild house mice-mortality following 
intubation with bromadiolone over a range of doses. 
Dosed 
(mg.kg-1) Sex Mortality 
2.9 male 1/3 
2.9 female 0/3 
5 .8 male 113 
5 .8 female 1/3 
11.5 male 0/3 
11.5 female 013 
34.5 male 016 
34.5 female 016 
Table 3. Anticoagulant-susceptible Swiss mice-mortality 
following intubation with bromadiolone. 
Dosed 
(mg.kg-1) Sex Mortality 
0 .9 male 0/10 
0 .9 female 0/10 
1.8 male 7/10 
1.8 female 7/10 
3.6 male 10/10 
3.6 female 10/ 10 
7.2 male 10/10 
7.2 female 10/10 
Breeding Experiments 
The inheritance of the bromadiolone resistance was 
examined by sening up a series of breeding experiments 
in which the putative resistance gene is represented by R, 
and its allele for susceptibility is represented by r. The 
principal type of design employed was the Test-Cross, in 
which the wild mouse of unknown genotype (RR, Rr or 
") is crossed with a mouse of the anticoagulant-
susceptible Swiss strain, which is of known genotype "· 
In a Test-Cross, assuming unifactorial dominant 
inheritance, the expected proportions of resistant offspring 
of homozygous resistant (RR), heterozygous (Rr) and 
homozygous susceptible(") parents are 1003, 503, and 
03 , respectively. If the Test-Cross offspring were given 
a dose of bromadiolone that would selectively kill 
susceptible animals, then assuming a dominant gene, 
mortality for offspring of homozygous resistant (RR), 
heterozygous (Rr) and homozygous susceptible (") parent 
would be 03, 503, and 1003, respectively. 
As a discriminating "Gavage Test" bromadiolone was 
administered at 10 mg.kg-1 body weight, a dose between 
5 .7 and 10.1 times greater than published LDso values, 
and which would be lethal to susceptible Swiss mice 
(Table 3), but that was much less than the maximum 
dose survived by the putative "resistant" Campus Main 
Water Distribution System Upgrade - Phase I house mice 
(Table 2). 
The results of Test-Crosses for 29 untreated wild mice 
are shown in Table 4. Significantly more females ( 10/14) 
than males (5/15) were homozygous resistant <x2 = 5.32; 
d.f. = l; p = 0.02), suggesting a sex-related effect on 
the fitness of the resistance genotype. 
Mortality using the male Test-Cross offspring was 
19.83 (39/197), slightly but not significantly greater than 
the 18.43 using the female Test-Cross offspring; 29/158 
(Qx2 = 0.049; d. f. = 1; p = 0.8-0. 9). 
Mortality among the offspring of putative 
heterozygotes was 443 (68/153), slightly less than the 
theoretical 503 <x2 = 1.67; d. f. = 1; p = 0.1 to 0.05). 
Litter size was substantially greater where the female 
parent was a Swiss mouse (mean litter size of 15. 7; 
compared with 8.6 for wild females), presumably owing 
to the superior mothering ability of the domesticated 
strain. 
If we define resistance as 100% survival, and 
susceptibility as 100% mortality in the Gavage Test, then 
the results are consistent with the hypothesis that the 
bromadiolone resistance is due to a single dominant 
autosomal gene. On this basis, assuming no selection 
within the population pen, the frequency of the resistance 
gene can be calculated to be 0. 74, and the theoretical 
frequencies of the RR, Rr, and " genotypes as 0.55, 
0.38, and 0.07, respectively. 
Development of Wild Homozygous Strains 
The breeding nucleus of a putatively homozygous 
resistant strain of pure wild ancestry was formed from the 
eight mice (two males and six females) indicated by 
asterisk in Table 3. To date all 40 of their offspring have 
received and survived a Gavage Test. 
The female mouse 94/16 (Table 3) was shown by the 
Test-Cross to be of the susceptible (rr) genotype. It was 
crossed with a wild heterozygote and the offspring were 
Test-Crossed. By this means, two homozygous 
susceptible (rr) offspring were identified, and were mated 
together to form the breeding nucleus of a bromadiolone-
susceptible strain of pure wild ancestry. The Gavage Test 
has given complete mortality in all eight of their offspring 
tested to date. 
DISCUSSION 
Published LDso values for bromadiolone are 0.99 
mg.kg·• (Meehan 1978) and 1.75 mg.kg ·1 (Grand 1976). 
Other published bromadiolone toxicity data against the 
house mouse refer to no-choice feeding tests, where the 
animals are fed bromadiolone bait, normally containing 
50 ppm of active ingredient for a pre-determined period 
of whole days. Since a mouse would normally consume 
between 10 to 20 mg.kg·• body weight of active ingredient 
per day, feeding on a 50 ppm formulation in a no-choice 
situation, this type of toxicity data is of little value in 
determining the toxicity of bromadiolone to a susceptible 
house mouse. 
The bromadiolone toxicity data presented for 
anticoagulant-susceptible Swiss mice in Table 3 
correspond well with the published acute oral LDso value 
of 1.75 mg.kg·• (Grand 1976), and provide support for the 
Gavage Test, that dosing at 10 mg.kg·1 is lethal to 
anticoagulant-susceptible mice. 
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Although the risk that the test misidentified a few 
animals cannot be excluded at this stage. the results of the 
breeding study strongly indicate a genetic basis for 
bromadiolone resistance in the wild "Reading" mice, 
which is consistent with a single dominant autosomal gene 
controlling the resistance phenotype. 
There are numerous reports in the literature of house 
mice suspected to be resistance to the second generation 
anticoagulant bromadiolone, based on their survival of a 
21-day feeding test on the field strength (50 ppm) 
formulation. 
Rowe et al. ( 1981) investigated the efficacy of 50 ppm 
bromadiolone against groups of house mice in a pen 
environment with alternative food available, and in six 
field treatments. Survivors from both the pen and the 
field were subjected to either a 50 ppm or a 100 ppm 
bromadiolone formulation for a no-choice feeding period 
of 21 days. Ten individuals survived after consuming 
between 118 and 410 mg.kg·1 body weight of 
bromadiolone. 
MacNicoll and Gill ( 1987) considered 11 out of 30 
wild house mice were resistant to bromadiolone following 
their survival of a 21-day feeding test on a 50 ppm 
bromadiolone formulation. 
Lund (1984) investigated the effect of bromadiolone 
against the Mus musculus species of house mice trapped 
from Denmark and southern Sweden, using no-choice 
feeding tests of up to ten days duration, and formulation 
strengths of 50 ppm and 100 ppm. He reported mice 
surviving following consumption of up to 115.8 mg.kg·• 
body weight of bromadiolone, and considered that this 
was resistance of practical importance. 
Unlike the major gene controlling warfarin-resistance 
in the house mouse (Wallace and MacSwiney 1976), the 
putative gene controlling bromadiolone resistance in the 
"Reading" mice would appear to be fully expressed in 
both males and females. This may be an artifact of the 
test doses chosen, since in resistance studies the 
expression of a gene always varies with the dose 
administered. 
Rowe and Redfern ( 1967) in a study with LAC Grey 
mice, noted that male mice were more susceptible to 
warfarin than female mice. The incomplete dominance of 
the warfarin resistance gene, as reported by Wallace and 
MacSwiney (1976) may indicate that the 21-day feeding 
test on a 250 ppm warfarin bait was too severe to 
effectively separate resistant from susceptible male 
individuals. Although this discriminating feeding period 
distinguished resistant and susceptible female mice 
effectively, a number of male warfarin-resistant mice 
must have died as a result of the feeding test, and have 
been misclassified. The original toxicity data of Rowe 
and Redfern (1964) made no attempt to establish a 
resistance baseline, and gave no mention of the increased 
susceptibility of male mice, which they were to report in 
their later publication. 
Although practical bromadiolone resistance occurs in 
field populations of house mice, the authors have as yet 
no evidence that the levels detected in the "Reading" 
stock are of significance. This will require further 
investigation. 
Table 4. Genotype detennination of wild house mice, by perfonning a Test Cross with an anticoagulant-
susceptible mouse, and testing the litter with a Gavage Test (dosing bromadiolone at 10 mg.kg·' body 
weight). 
Animal Test Cross Litter 
Mortality following Intubation of 
Bromadiolone at 10 mg.kg·' Suspected Resistance 
No. Sex Males Females Males Females Status of Wild Parent 
93/l* male 4 7 0/4 011 RR 
93/2* male 5 9 3/5 3/9 Rr 
93/3* female 6 4 016 0/4 RR 
93/5* female 3 7 013 011 RR 
93/6* female 11 0 0/11 010 RR 
9317* female 7 2 011 0/2 RR 
93/8* female 9 0/1 019 RR 
9319* female 7 0/1 011 RR 
93/10 male 6 8 4/6 618 Rr 
93/11 * male 6 6 016 0/6 RR 
93/12 male 11 8 9/11 3/8 Rr 
93/13 male 6 8 1/6 118 Rr 
93/14 male 6 5 2/6 215 Rr 
94/l male 8 6 4/8 1/6 Rr 
94/2 male 8 5 618 3/5 Rr 
94/3 female 4 4 2/4 .l/4 Rr 
94/4 male 7 5 511 115 Rr 
9415 male 7 7 217 211 Rr 
94/6 male 3 4 113 0/4 Rr 
9417 male 7 5 011 015 RR 
94/8 male 5 10 015 0/10 RR 
94/12 female 5 2 2/5 012 Rr 
94/13 female 5 3 015 0/3 RR 
94/15 female 4 3 0/4 0/3 RR 
94/16 female 4 5 4/4 515 
" 
94/17 male 6 8 016 0/8 RR 
94/18 female 5 3 015 0/3 RR 
94/20 female 4 5 0/4 015 RR 
94/21 female 3 3 3/3 113 Rr 
RR = homozygous resistant 
Rr = heterozygous resistant 
" = homozygous susceptible 
*This was ref erred to earlier in text. 
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